Effect of Neutrophil Depletion on Gelatinase Expression, Edema Formation and Hemorrhagic Transformation After Focal Ischemic Stroke

Overview

Journal BMC Neurosci

Publisher Biomed Central

Specialty Neurology

Date 2005 Aug 5

PMID 16078993

Citations 42

Authors

Alex K Harris

Adviye Ergul

Anna Kozak

Livia S Machado

Maribeth H Johnson

Susan C Fagan

Affiliations

Soon will be listed here.

Abstract

Background: While gelatinase (MMP-2 and -9) activity is increased after focal ischemia/reperfusion injury in the brain, the relative contribution of neutrophils to the MMP activity and to the development of hemorrhagic transformation remains unknown.

Results: Anti-PMN treatment caused successful depletion of neutrophils in treated animals. There was no difference in either infarct volume or hemorrhage between control and PMN depleted animals. While there were significant increases in gelatinase (MMP-2 and MMP-9) expression and activity and edema formation associated with ischemia, neutrophil depletion failed to cause any change.

Conclusion: The main finding of this study is that, in the absence of circulating neutrophils, MMP-2 and MMP-9 expression and activity are still up-regulated following focal cerebral ischemia. Additionally, neutrophil depletion had no influence on indicators of ischemic brain damage including edema, hemorrhage, and infarct size. These findings indicate that, at least acutely, neutrophils are not a significant contributor of gelatinase activity associated with acute neurovascular damage after stroke.

Citing Articles

Neutrophil Extracellular Traps Regulate Surgical Brain Injury by Activating the cGAS-STING Pathway.

Li B, Xu L, Wang Z, Shi Q, Cui Y, Fan W Cell Mol Neurobiol. 2024; 44(1):36.

PMID: 38637346 PMC: 11026279. DOI: 10.1007/s10571-024-01470-9.

Neutrophil dynamics and inflammaging in acute ischemic stroke: A transcriptomic review.

Bui T, Jickling G, Winship I Front Aging Neurosci. 2023; 14:1041333.

PMID: 36620775 PMC: 9813499. DOI: 10.3389/fnagi.2022.1041333.

Bone marrow-derived extracellular vesicles modulate the abundance of infiltrating immune cells in the brain and exert an antiviral effect against the Japanese encephalitis virus.

Soni N, Tripathi A, Mukherjee S, Gupta S, Mohanty S, Basu A FASEB Bioadv. 2022; 4(12):798-815.

PMID: 36479206 PMC: 9721092. DOI: 10.1096/fba.2022-00071.

Neutrophils delay repair process in Wallerian degeneration by releasing NETs outside the parenchyma.

Yamamoto Y, Kadoya K, Terkawi M, Endo T, Konno K, Watanabe M Life Sci Alliance. 2022; 5(10).

PMID: 35961782 PMC: 9375156. DOI: 10.26508/lsa.202201399.

Inflammatory Responses After Ischemic Stroke.

DeLong J, Ohashi S, OConnor K, Sansing L Semin Immunopathol. 2022; 44(5):625-648.

PMID: 35767089 DOI: 10.1007/s00281-022-00943-7.

References

Ergul A, Portik-Dobos V, Giulumian A, Molero M, Fuchs L . Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation. Am J Physiol Heart Circ Physiol. 2003; 285(5):H2225-32. DOI: 10.1152/ajpheart.00133.2003. View

Fagan S, Nagaraja T, Fenstermacher J, Zheng J, Johnson M, Knight R . Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model. Neurol Res. 2003; 25(4):377-82. DOI: 10.1179/016164103101201526. View

Hilali H, Simpkins A, Hill W, Waller J, Knight R, Fagan S . Single slice method for quantification of hemorrhagic transformation using direct ELISA. Neurol Res. 2004; 26(1):93-8. DOI: 10.1179/016164104773026606. View

Fagan S, Hess D, Hohnadel E, Pollock D, Ergul A . Targets for vascular protection after acute ischemic stroke. Stroke. 2004; 35(9):2220-5. DOI: 10.1161/01.STR.0000138023.60272.9e. View

Maier C, Hsieh L, Yu F, Bracci P, Chan P . Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia. Stroke. 2004; 35(5):1169-74. DOI: 10.1161/01.STR.0000125861.55804.f2. View

Smeglin A, Frishman W . Elastinolytic matrix metalloproteinases and their inhibitors as therapeutic targets in atherosclerotic plaque instability. Cardiol Rev. 2004; 12(3):141-50. DOI: 10.1097/01.crd.0000105000.46909.81. View

Bederson J, Pitts L, Tsuji M, Nishimura M, Davis R, Bartkowski H . Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986; 17(3):472-6. DOI: 10.1161/01.str.17.3.472. View

Swanson R, Morton M, Savalos R, Davidson C, Sharp F . A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990; 10(2):290-3. DOI: 10.1038/jcbfm.1990.47. View

Lin T, He Y, Wu G, Khan M, Hsu C . Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993; 24(1):117-21. DOI: 10.1161/01.str.24.1.117. View

10.

Hamann G, Okada Y, Fitridge R, Del Zoppo G . Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke. 1995; 26(11):2120-6. DOI: 10.1161/01.str.26.11.2120. View

11.

Rosenberg G, Navratil M, Barone F, Feuerstein G . Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab. 1996; 16(3):360-6. DOI: 10.1097/00004647-199605000-00002. View

12.

Chopp M, Li Y, Jiang N, Zhang R, Prostak J . Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab. 1996; 16(4):578-84. DOI: 10.1097/00004647-199607000-00007. View

13.

Knight R, Barker P, Fagan S, Li Y, Jacobs M, Welch K . Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke. 1998; 29(1):144-51. DOI: 10.1161/01.str.29.1.144. View

14.

Romanic A, White R, Arleth A, Ohlstein E, Barone F . Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke. 1998; 29(5):1020-30. DOI: 10.1161/01.str.29.5.1020. View

15.

Mun-Bryce S, Rosenberg G . Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab. 1998; 18(11):1163-72. DOI: 10.1097/00004647-199811000-00001. View

16.

Fagan S, Garcia J . Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activator. Pharmacotherapy. 1999; 19(2):139-42. DOI: 10.1592/phco.19.3.139.30932. View

17.

Heo J, Lucero J, Abumiya T, Koziol J, Copeland B, Del Zoppo G . Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab. 1999; 19(6):624-33. DOI: 10.1097/00004647-199906000-00005. View

18.

Nagase H, Woessner Jr J . Matrix metalloproteinases. J Biol Chem. 1999; 274(31):21491-4. DOI: 10.1074/jbc.274.31.21491. View

19.

Gasche Y, Fujimura M, Copin J, Kawase M, Massengale J, Chan P . Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab. 1999; 19(9):1020-8. DOI: 10.1097/00004647-199909000-00010. View

20.

Yang Y, Li Q, Miyashita H, Howlett W, Siddiqui M, Shuaib A . Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia. J Neurosurg. 2000; 92(5):841-7. DOI: 10.3171/jns.2000.92.5.0841. View